-- EUROPE RESEARCH ROUNDUP-Aberdeen Asset Management, Hugo Boss  
-- 
-- Thu Oct 02, 2014 01:55AM EDT
-- None



Oct 2 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Swiss Life and Dechra Pharmaceuticals, on Thursday.

HIGHLIGHTS * Aberdeen Asset Management <ADN.L>: Jefferies raises to hold from underperform * Dechra Pharmaceuticals <DECP.L>: Jefferies starts with buy; target price of 871p * Hugo Boss <BOSSn.DE>: Jefferies starts with buy rating * Swiss Life <SLHN.VX>: Morgan Stanley ups to equal-weight from underweight Following is a summary of research actions on European companies reported by Reuters on Thursday. Stock entries are in alphabetical order.* Aberdeen Asset Management <ADN.L>: Jefferies raises to hold from underperform * Aberdeen Asset Management <ADN.L>: Jefferies raises price target to 400p from 350p * Dechra Pharmaceuticals <DECP.L>: Jefferies starts with buy; target price of 871p * Go-Ahead Group <GOG.L>: Panmure raises target price to 2900p from 2500p; rating buy * Hugo Boss <BOSSn.DE>: Jefferies starts with buy rating * Hugo Boss <BOSSn.DE>: Jefferies starts with price target 115 euros * Jeronimo Martins <JMT.LS>: Barclays cuts target to 8 euros from 9.90 euros; underweight * Novo Nordisk <NOVOb.CO>: Morgan Stanley starts with equal-weight rating * Raiffeisen Bank International <RBIV.VI>: Barclays cuts target to 21.70 euros from 24.70 * SSAB <SSABa.ST>: Citigroup cuts target price to Sek 75 from Sek 80; rating buy * Swiss Life <SLHN.VX>: Morgan Stanley ups to equalweight from underweight;target to Sfr 244